The Raf/MEK/ERK pathway can govern drug resistance, apoptosis and sensitivity to targeted therapyStephen L. Abrams, James A. McCubrey, Franca Stivala et al.|Cell Cycle|2010Cited by 136
Dominant roles of the Raf/MEK/ERK pathway in cell cycle progression, prevention of apoptosis and sensitivity to chemotherapeutic drugsLinda S. Steelman, James A. McCubrey, Stephen L. Abrams et al.|Cell Cycle|2010Cited by 44
Enhancing therapeutic efficacy by targeting non-oncogene addicted cells with combinations of signal transduction inhibitors and chemotherapyStephen L. Abrams, James A. McCubrey, Alberto M. Martelli et al.|Cell Cycle|2010Cited by 27